FBRX · ISSUER CIK 1419041
Forte Biosciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Forte Biosciences, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 202616:36 | Aug 27, 2026 | FBRX | Director | U · Other | — | −3,960 | 0 | -100% | — | ||
| Aug 27, 202616:33 | Aug 27, 2026 | FBRX | Director | U · Other | — | −5,940 | 0 | -100% | — | ||
| Aug 27, 202616:28 | Aug 27, 2026 | FBRX | CHIEF FINANCIAL OFFICER | U · Other | — | −42,600 | 0 | -100% | — | ||
| Aug 27, 202616:28 | Aug 27, 2026 | FBRX | SEE REMARKS, Director | U · Other | — | −85,482 | 0 | -100% | — |